// App-Quantinova.ai

7511 : Prediction of therapeutic outcomes in DLBCL from circulating tumor DNA dynamics.

Researchers

Presenter

  • David Matthew Kurtz

Principal Investigators

  • Florian Scherer

  • Aaron M. Newman

  • Alexander F.M. Craig

  • Michael Siavash Khodadoust

  • Alexander F. Lovejoy

  • Daniel M. Klass

  • Jacob J. Chabon

  • Cynthia Glover

  • Li Zhou

  • Chih Long Liu

  • Neel K. Gupta

  • Lauren Shizue Maeda

  • Ranjana H. Advani

  • Ronald Levy

  • Maximilian Diehn

  • Ash A. Alizadeh

Medical Centers

  • Division of Oncology, Stanford University School of Medicine, Stanford, CA

  • Roche Molecular Systems, Pleasanton, CA

  • Institute for Stem Cell Biology and Regenerative Medicine, Stanford, CA

  • Stanford Hospital Stanford Cancer Center, Palo Alto, CA

  • Stanford School of Medicine, Stanford, CA

  • Stanford Comp Cancer Center, San Mateo, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

Biomarkers

  • Circulating DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved